carcinogen es is 22

Upload: okki-masitah-syahfitri-nasution

Post on 13-Apr-2018

222 views

Category:

Documents


2 download

TRANSCRIPT

  • 7/27/2019 Carcinogen Es is 22

    1/40

    CarcinogenesisProfessor Dr Nor Hayati Othman

    Pathology Department

  • 7/27/2019 Carcinogen Es is 22

    2/40

  • 7/27/2019 Carcinogen Es is 22

    3/40

    CarcinogenesisOverview

    NeoplasiaDefinitions

    Hypotheses of the Origin of Neoplasia

    Agents Causing Neoplasia

  • 7/27/2019 Carcinogen Es is 22

    4/40

    CarcinogenesisNeoplasia

    NeoplasiaLatin, new growth

    Cancercrab

    Rupert Willis, 1950s

  • 7/27/2019 Carcinogen Es is 22

    5/40

    Carcinogenesis - Overview

    Neoplasia is an abnormality of cell growthand multiplication characterised by

    At cellular level

    Excessive cellular proliferation Uncoordinated growth

    Tissue infiltration

    At molecular level

    Disorder of growth regulatory genes Develops in a multistep fashion

  • 7/27/2019 Carcinogen Es is 22

    6/40

    CarcinogenesisOverview

    Hypotheses of the Origin of Neoplasia

    1. Oncogenes and Tumor Suppresor Genes

    2.

    Viral Oncogene Hypothesis3. Epigenetic Hypothesis

    4. Failure of Immune Surveillance

    Agents Causing Neoplasia

  • 7/27/2019 Carcinogen Es is 22

    7/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    Origin of Neoplasia two general types

    Monoclonal

    Initial neoplastic change affects a single cell

    Field origin

    Carcinogen acts on large number of cells

    producing field of potentially neoplastic cells

  • 7/27/2019 Carcinogen Es is 22

    8/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    Multiple Hits and Multiple Factors Knudson proposed that carcinogenesis requires 2

    hits 1steventinitiation

    Carcinogen = initiator

    2ndeventpromotion

    Agent = promoter

    Multiple hits occur5 or more

    Each hit produces a change in the genome which istransmitted to its progeny (ie. clone)

    Lag period Time between exposure (first hit) and development of

    clinically apparent cancer

    Altered cell shows no abnormality during lag period

  • 7/27/2019 Carcinogen Es is 22

    9/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    1 Oncogenes and Tumor Suppresor Genes Two categories of cell regulatory genes

    Proto-oncogenes (cellular oncogene, c-onc)

    Tumor suppressor gene

    Proto-oncogenes code for Growth factors

    Receptors

    Signal-relay or transduction factors

    Tumor suppressor genes code for factors thatdown-regulate the cell cycle P53

    Rb

  • 7/27/2019 Carcinogen Es is 22

    10/40

    NORMAL CELLGrowth factorGrowth factor receptor

    Signal transduction

    Activation oftranscription

    cytoplasm

    nucleus

  • 7/27/2019 Carcinogen Es is 22

    11/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    1 Oncogenes and Tumor Suppresor

    Genes

    Gene Activation and Inactivation

    Proto-oncogene is activated or tumor

    suppressor gene is inactivated

    normal growth regulation is diverted into

    oncogenesis

    Activated proto-oncogene = activated

    oncogene, mutant oncogene, cellular oncogene

  • 7/27/2019 Carcinogen Es is 22

    12/40

    point mutation

    translocation

    gene amplification

    How does proto-oncogene

    get activated?

  • 7/27/2019 Carcinogen Es is 22

    13/40

    Relationship between gene products ofproto oncogene

    Growth factors eg IGFGrowth factor receptorsEg erb-2, ret

    Signal transducingfactorsEg cytoplasmic

    kinases

    DNA bindingproteins

    concerned withtranscription

    cell cycle

    proteins egcyclin D

  • 7/27/2019 Carcinogen Es is 22

    14/40

    NEOPLASTIC CELLS

    Increased

    In growthfactor

    Increased

    In growthfactorreceptors

    Increased in

    signaltransduction

    Increase inactivation oftranscription

  • 7/27/2019 Carcinogen Es is 22

    15/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    2 Viral Oncogene Hypothesis

    RNA Retrovirusproduces DNA provirus DNA provirus containing viral oncogene (v-onc)

    is introduced, or DNA provirus without v-onc is inserted adjacent

    to c-onc in host cell DNA

    RNA viruses is thought to have acquired v-oncsequence by recombinant mechanism fromanimal cells

    DNA virus Do not contain viral oncogenes

    Act by blocking suppressor gene products

    ExamplesHPV, EBV,HBV

  • 7/27/2019 Carcinogen Es is 22

    16/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    3 Epigenetic Hypothesis

    Changes in the regulation of geneexpression rather than in the geneticapparatus

    Pattern of gene expressionsresponsible for tissue differentiation

    (ie. epigenetic mechanism) arethought to be heritable

  • 7/27/2019 Carcinogen Es is 22

    17/40

    CarcinogenesisHypotheses of the Origin of Neoplasia

    4 Failure of Immune Surveillance

    Concepts

    Neoplastic changes frequently occur incells

    Altered DNA result in production ofneoantigens & tumor-associatedantigens

    Immune response (cytotoxic) toneoantigens as foreign antigens

    Neoplastic cells escaping recognition

    and destruction become clinical cancers

  • 7/27/2019 Carcinogen Es is 22

    18/40

    Feeling sleepy

    yawwwwwwwn!

  • 7/27/2019 Carcinogen Es is 22

    19/40

    CarcinogenesisOverview

    NeoplasiaDefinitions

    Hypotheses of the Origin of Neoplasia

    Agents Causing Neoplasia

    Chemical Oncogensis

    Radiation Oncogenesis

    Viral Oncogenesis

    Nutritional OncogenesisHormonal Oncogenesis

    Genetic Oncogenesis

  • 7/27/2019 Carcinogen Es is 22

    20/40

    CarcinogenesisAgents Causing Neoplasm

    Carcinogenssubstances known tocause cancer or produces an increasein incidence of cancer in animals or

    humansCause of most cancers is unknown

    Most cancers are probably multifactorial inorigin

    Known carcinogenic agents constitute asmall percentage of cases

    Unidentified environmental agents

    probably play a role in 95% of cancers

  • 7/27/2019 Carcinogen Es is 22

    21/40

    CarcinogenesisAgents Causing Neoplasm

    1 - Chemical Carcinogenesis

    Types

    Proximate or direct-acting : act locallywithout metabolic change

    Indirect acting: carcinogenic only after

    being metabolised into active

    compounds (procarcinogen ultimatecarcinogen)

  • 7/27/2019 Carcinogen Es is 22

    22/40

    CarcinogenesisAgents Causing Neoplasm

    Mode of carcinogenesis Inducing changes in DNAeg. Base alkylation,

    deletion, breakage, cross-linkage

    Epigenetic mechanisms

    Synergistic action with viruses

    Promoter for other carcinogens

    Difficulties in identifying carcinogen

    Numerous industrial, agricultural, householdchemicals present in low levels

    Exposed to large number of chemicals in alifetime

    Long lag phase

  • 7/27/2019 Carcinogen Es is 22

    23/40

    CarcinogenesisAgents Causing Neoplasm

    2 Radiation Oncogenesis

    Types of oncogenic radiation Ultraviolet

    X-ray Radioisotopes

    Nuclear Fallout

    Mode of oncogenesis Direct effect on DNA

    Activation of cellular oncogenes

  • 7/27/2019 Carcinogen Es is 22

    24/40

    CarcinogenesisAgents Causing Neoplasm

    UV Radiation

    Solar UV radiation associated with skin cancers

    squamous CA, basal cell CA, malignant

    melanoma Fair-skinned and elderly are susceptible

    UV light is believed to induce cross-linkages

    between DNA molecules and CA occurs when

    repair mechanisms are not efficient

  • 7/27/2019 Carcinogen Es is 22

    25/40

    CarcinogenesisAgents Causing Neoplasm

    X-ray radiation

    Earlier use of X-rays caused skincancer, leukemia and papillary thyroid

    CARadiotherapy causes raditation-induced

    malignancy 10-30 yrs laterusuallysarcomas

    Diagnostic X-rays are considered tohave no increased risk except inabdominal x-rays which increaseincidence of leukemia in the fetus

  • 7/27/2019 Carcinogen Es is 22

    26/40

    CarcinogenesisAgents Causing Neoplasm

    Radioisotopes

    Osteosarcoma common among factory workers

    who use radium-containing paints

    Radioactive mineral mining in Europe and USAassociated with lung cancer

    Thorium increases risk of liver cancer

    hepatocellular, angiosarcoma,

    cholangiocarcinoma Radioactive iodineincreased risk of cancer

    15-25 years later

  • 7/27/2019 Carcinogen Es is 22

    27/40

    CarcinogenesisAgents Causing Neoplasm

    Nuclear Fallout

    Hiroshima, Nagasaki (atomic blasts)

    Marshall islands (atmospheric testing of nuclear

    divide containing radioactive iodine) Chernobyl, 1986

  • 7/27/2019 Carcinogen Es is 22

    28/40

    CarcinogenesisAgents Causing Neoplasm

    3 Viral Oncogenesis

    Types

    Oncogenic RNA VirusesOncogenic DNA Viruses

    Mode of Oncogenesis

    RNA VirusDNA Virus

  • 7/27/2019 Carcinogen Es is 22

    29/40

    CarcinogenesisAgents Causing Neoplasm

    Detection of viral genome

    Identification of viral-specific nucleic acid

    sequences by hybridisation with DNA/RNA

    probes Recognition of virus-specific antigens on

    infected cells

    Detection of virus-specific mRNA

  • 7/27/2019 Carcinogen Es is 22

    30/40

    CarcinogenesisAgents Causing Neoplasm

    4 Nutritional Oncogenesis Scant evidence linking cancer to diet except for

    known chemical carcinogens

    Some associations Low-fiber diet and colonic CA

    Fatty diet with breast ca

    Betel leaves with oral ca

    Protective agents?antioxidant effect, awaitingconfirmation Beta-carotene

    Vitamin C, E

    Selenium

  • 7/27/2019 Carcinogen Es is 22

    31/40

    CarcinogenesisAgents Causing Neoplasm

    5 Hormonal Oncogenesis

    Types

    Induction of Neoplasms by Hormones

    Dependence of Neoplasms on Hormones

    Hormones inducing Neoplasms

    Estrogenbreast ca

    Diethylstilbestrol (DES)vaginal and uterineca

  • 7/27/2019 Carcinogen Es is 22

    32/40

    CarcinogenesisAgents Causing Neoplasm

    Hormonal Dependence of Neoplasms

    Neoplasm not caused by hormones but dependon hormones for optimal growth

    Neoplastic cells possess receptors for binding

    hormone Loss of hormonal stimulation slow but does not

    halt growth

    Examples

    Prostate CA Breast CA

    Thyroid CA

  • 7/27/2019 Carcinogen Es is 22

    33/40

    CarcinogenesisAgents Causing Neoplasm

    6 - Genetic Oncogenesis (Role ofInheritance)

    Types

    Mendelian inheritance Polygenic inheritance

    Association with inherited diseases

    Mendelian Inheritance

    Dominant Recessive

  • 7/27/2019 Carcinogen Es is 22

    34/40

    CarcinogenesisAgents Causing Neoplasm

    Examples

    Retinoblastoma

    Wilms tumor

    Others Neurofibromatosis (type 1 von

    Recklinghausens disease)

    Multiple endocrine adenomatosis (MEN)

    Familial polyposis coli

    Nevoid basal cell carcinoma syndrome

  • 7/27/2019 Carcinogen Es is 22

    35/40

    CarcinogenesisAgents Causing Neoplasm

    Polygenic Inheritance

    Neoplasms occuring in related

    individuals more often than expected on

    the basis of chance Breast CA

    Colon CA

  • 7/27/2019 Carcinogen Es is 22

    36/40

    CarcinogenesisAgents Causing Neoplasm

    Association with Inherited Diseases

    Many inherited diseases are associated

    with higher risk of neoplasia

    Types :

    Syndromes characterised by increased

    chromosomal fragility

    Syndromes of immunodeficiency

  • 7/27/2019 Carcinogen Es is 22

    37/40

    I am yawning

  • 7/27/2019 Carcinogen Es is 22

    38/40

    conclusion

    Pathogenesis of cancer iscomplex

    it is a genetic disease- either

    acquired genetic abnormality orinherited genetic abnormality

    It arises when several mutations

    accumulate within genome

  • 7/27/2019 Carcinogen Es is 22

    39/40

    conclusionAdded insults from the

    environmental exposures tocarcinogens : chemicals,

    radiation, virusesGrowth autonomy from

    activation of growth factors or by

    suppression of tumoursuppressor genes

  • 7/27/2019 Carcinogen Es is 22

    40/40

    Acquired environmental factorschemicals ,radiation ,viruses

    Changes in genomeof somatic cells

    Activation of growthpromoting oncogenes

    Inactivation of cancersupressor genes

    Expression all altered gene productsand loss of regular gene products

    MALIGNANT NEOPLSM

    Genetic factor